Pathogen Sample Collection, Transport and Processing

PrimeStore® Molecular Transport Medium to inactivate viruses and pathogens

Ensuring safe collection and transportation of pathogenic samples. A novel viral transport media to help in the fight against COVID-19 and other infectious diseases

PrimeStore® MTM is a molecular transport media that safely inactivates microbes whilst stabilising and preserving the released DNA and RNA for downstream molecular applications including Next Generation Sequencing and qPCR.

This Molecular Transport Media was designed and optimised for molecular testing allowing pathogenic samples to be collected, transported, and processed safely and efficiently. PrimeStore® MTM has been a vital tool during the SARS-CoV-2/COVID-19 pandemic.

PrimeStore® MTM provides safer and more reliable testing than universal transport media (UTM), viral transport media (VTM), saline, or research-use only devices.

PrimeStore® MTM Benefits

• Effectively kills viral and bacterial pathogens whilst stabilising and preserving RNA and DNA
• Eliminate the cold chain requirements for sample collection and transportation
• Reduces safety risks of handling pathogenic samples
• Single tune for collection, inactivation, shipping, and storage
• For use with COVID-19, flu A, flu B, HIV, TB and more

Suitable PrimeStore® MTM Sample Types

• Sputum
• Swabs (throat, nasal, nasopharyngeal, buccal)
• Blood/plasma/serum
• Nasal washes
• Urine/Fecal
• Vector-borne
• Tissue
• Food samples
• Environmental

Unlike most sample collection systems PrimeStore MTM alleviates cold chain requirements for sample collection and transportation, ensuring RNA stability for 7 days at ambient temperatures or 28 days at 2-8C.

Long-term frozen storage

The PrimeStore MTM collection tube is optimised for short, medium- and long-term storage as samples placed in PrimeStore MTM are ready for biobanking with no requirements for additional supplies.

Read more:

• Viral Molecular Transport Medium for Safer, Faster, No Cold Chain Shipping and Testing During COVID-19
• VIRAL TRANSPORTATION IN COVID-19 PANDEMIC: INACTIVATED VIRUS TRANSPORTATION SHOULD BE IMPLEMENTED FOR SAFE TRANSPORTATION AND HANDLING AT DIAGNOSTICS LABORATORIES
• A Clinical Specimen Collection and Transport Medium for Molecular Diagnostic and Genomic Applications.
•  A “One-Health” Approach for Diagnosis and Molecular Characterization of SARS-CoV-2 in Italy.
•  Laboratory Evaluation of a Specimen Transport Medium for Downstream Molecular Processing of Sputum Samples to Detect Mycobacterium tuberculosis. 
• Inactivation analysis of SARS-CoV-2 by specimen transport media, nucleic acid extraction reagents, detergents and fixatives